Hospital General Universitario de Valencia -ko ikertzaileekin lankidetzan egindako argitalpenak (39)

2022

  1. Current clinical spectrum of common variable immunodeficiency in Spain: The multicentric nationwide GTEM-SEMI-CVID registry

    Frontiers in Immunology, Vol. 13

  2. Frequency and characteristics of HTLV in migrants: results from the +Redivi collaborative network in Spain

    Journal of travel medicine, Vol. 29, Núm. 7

  3. The EPICTER score: a bedside and easy tool to predict mortality at 6 months in acute heart failure

    ESC Heart Failure, Vol. 9, Núm. 4, pp. 2348-2356

  4. Trends in imported malaria during the COVID-19 pandemic, Spain (+Redivi Collaborative Network)

    Journal of travel medicine, Vol. 29, Núm. 6

2021

  1. Follow-up care over 12months of patients with prostate cancer in Spain A multicenter prospective cohort study

    Medicine (United States), Vol. 100, Núm. 47

  2. Implementation of pre-exposure prophylaxis programme in Spain. Feasibility of four different delivery models

    PLoS ONE, Vol. 16, Núm. 2 February

  3. Use of antihyperglycaemic therapy with cardiovascular benefit in patients with type 2 diabetes who require hospitalisation: A cross-sectional study

    Revista Clinica Espanola, Vol. 221, Núm. 9, pp. 517-528

2020

  1. Deprescribing of non-antiretroviral therapy in HIV-infected patients

    European Journal of Clinical Pharmacology, Vol. 76, Núm. 3, pp. 305-318

  2. Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients

    AIDS (London, England), Vol. 34, Núm. 10, pp. 1497-1507

  3. Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Clinicoepidemiological characteristics of viral hepatitis in migrants and travellers of the +Redivi network

    Travel Medicine and Infectious Disease, Vol. 29, pp. 51-57

  2. Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients

    AIDS, Vol. 33, Núm. 2, pp. 269-278

  3. Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Dysregulation of the immune system in HIV/HCV-coinfected patients according to liver stiffness status

    Cells, Vol. 7, Núm. 11

  2. Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients

    AIDS, Vol. 32, Núm. 11, pp. 1423-1430

2017

  1. Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia

    Clinical Microbiology and Infection, Vol. 23, Núm. 1, pp. 49.e1-49.e8

  2. Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance

    Clinical Microbiology and Infection, Vol. 23, Núm. 9, pp. 672.e1-672.e11

  3. Week 4 response predicts sustained virological response to all-oral direct-acting antiviral-based therapy in cirrhotic patients with hepatitis C virus genotype 3 infection

    Clinical Microbiology and Infection, Vol. 23, Núm. 6, pp. 409.e5-409.e8

2016

  1. Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score–derived analysis of a population-based, multicentre prospective cohort

    Clinical Microbiology and Infection, Vol. 22, Núm. 8, pp. 733.e1-733.e8

  2. Travelers' diarrhea in children at risk: An observational study from a Spanish database

    Pediatric Infectious Disease Journal, Vol. 35, Núm. 4, pp. 392-395